Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Monoclonal Gammopathy
Complete Blood Count with differential (CBC w/ diff)
+1 more
Locations
1
United States
Levine Cancer Institute
Charlotte, North Carolina, United States
Start Date
June 1, 2026
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2027
Last Updated
April 16, 2026
NCT06383143
NCT05529069
NCT05442515
NCT02269592
NCT03050268
NCT03938987
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions